Vaginal lactobacilli produce anti-inflammatory β-carboline compounds

Cecilia Webber,Virginia Glick,Morgan Martin,Cecilia Kim,Maryam Ahmad,Lauren Simmons,Sunghee Bang,Michael Chao,Nicole Howard,Sarah Fortune,Lalit Beura,Seo Yoon Lee,Jon Clardy,Ki Hyun Kim,Smita Gopinath

DOI: https://doi.org/10.1101/2024.02.19.580919

2024-02-19

Abstract:The vaginal microbiome is a lactobacilli-dominant, human-adapted community consistently found in people around the world. Presence of lactobacilli-dominant vaginal microbial communities, apart from is associated with reduced vaginal inflammation and reduced levels of pro-inflammatory cytokines. Loss of lactobacilli-dominance is associated with inflammatory conditions such as bacterial vaginosis. It remains unclear if health-associated lactobacilli actively promote the anti-inflammatory immune homeostasis of the vaginal mucosa and if so, by which mechanisms. We have identified that a key vaginal bacterial species, secretes a family of β-carboline compounds with anti-inflammatory activity. These compounds suppress NFκB and interferon signaling downstream of multiple pattern recognition receptors in human macrophages and significantly dampen type I interferon receptor activation. Topical vaginal application of an anti-inflammatory β-carboline compound, perlolyrine, was sufficient to significantly reduce vaginal inflammation in a mouse model of genital herpes infection. Together, we identify a key family of compounds by which vaginal lactobacilli mediate host immune homeostasis and could highlight a new therapeutic avenue for vaginal inflammation.

Microbiology

What problem does this paper attempt to address?

This paper mainly discusses how vaginal lactobacilli affect the vaginal immune environment, specifically whether they can actively maintain an anti-inflammatory state of the vaginal mucosa. The study found that one key vaginal bacterial species, Lactobacillus crispatus, secretes a compound family called β-carbolines, which have anti-inflammatory activity. They can inhibit the NFkB and interferon signaling pathways in human macrophages, reducing inflammation triggered by various pattern recognition receptors. In a mouse model, local application of anti-inflammatory β-carboline compounds significantly reduced vaginal inflammation caused by genital herpes infection.

The study also pointed out that the vaginal microbiota associated with the dominant population of Lactobacillus is related to health status, including reduced risk of sexually transmitted infections, preterm birth, and inflammation levels. Conversely, the loss of dominant status of Lactobacillus is associated with conditions such as bacterial vaginosis and inflammation. The paper excluded other species in the Lactobacillus genus, such as L. iners, which do not produce similar anti-inflammatory compounds, through experiments.

In addition, the researchers isolated and identified these compounds and found that they can inhibit specific signaling pathways of immune cells, such as nuclear factor κB (NFkB) and type I interferon (IFN) activation, thereby reducing inflammation. In a mouse model, application of β-carboline compounds alleviated vaginal inflammation caused by viral infection, even with the same viral load, and reduced the severity of the disease.

In conclusion, this study reveals that vaginal lactobacilli regulate the host immune environment by secreting β-carboline compounds, suggesting a possible new strategy for the treatment of vaginal inflammation.